Abstract
Background
Tobacco is a risk factor for oral squamous cell carcinoma (OSCC). Some cases of OSCC occur without any known cause and is called idiopathic OSCC. Understanding proteomic signatures in tissues of patients in these two groups is crucial for understanding etio-pathogenic pathways involved in cancer causation.
Methods
Five biopsy tissue samples, each from ulcero-proliferative growth of histopathologically proven squamous cell carcinoma, were taken from habitual tobacco consumers and non-tobacco consumers. Proteins were extracted, reduced, alkylated, trypsin digested, and desalted using C18 column. Label-free proteomics was carried out by subjecting 1 µg of peptides from each of the samples to mass spectrometric analysis on an Orbitrap Exploris 240 using data-dependent acquisition mode. Raw files were processed using Proteome Discoverer (v2.4), and differentially expressed proteins were normalized and identified using Shiny Protigy (v1.1.7). Principal component analysis was performed using ClustVis to look for variance between the two groups. String App plugin in Cytoscape version 3.10.0 was employed to construct a comprehensive interaction network for the differentially expressed proteins.
Results
828 proteins were identified in all samples. Proteins SGT1 homolog, eukaryotic translation initiation factor 4H, small ribosomal subunit protein Es1, and stromal interaction molecule—isoform of Q13586 were upregulated in cancer tissues of tobacco consumers, while dihydropyrimidinase-related protein 2, peptidyl-prolyl cis–trans isomerase, tetraspanin (CD63), and cytochrome C were upregulated in cancer tissues of non-tobacco consumers. Two clinical phenotypes were distinctly segregated based on differential expression of these proteins.
Conclusion
There are differentially expressed proteins in oral cavity tissues of tobacco users and non-tobacco users. These proteins are implicated in causation of cancer by distinct pathways in the two phenotypes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Abu-Rmaileh A, Solaimuthu B, Khatib A, Lavi S, Tanna M, Hayashi A, Ben Yosef M, Lichtenstein M, Pillar N, Shaul YD (2022) DPYSL2 interacts with JAK1 to mediate breast cancer cell migration. J Cell Biol. https://doi.org/10.1083/jcb.202106078
Akintade DD, Chaudhuri B (2023) FK506-binding protein 2 (FKBP13) inhibit Bax-induced apoptosis in Saccharomyces cerevisiae (yeast). Cell Biol Toxicol 39:719–728. https://doi.org/10.1007/s10565-021-09633-w
Bai J, Wu L, Wang X, Wang Y, Shang Z, Jiang E, Shao Z (2022) Roles of mitochondria in oral squamous cell carcinoma therapy: friend or foe? Cancers. https://doi.org/10.3390/cancers14235723
Bhat FA, Mohan SV, Patil S, Advani J, Bhat MY, Patel K, Mangalaparthi KK, Datta KK, Routray S, Mohanty N, Nair B, Mandakulutur SG, Pal A, Sidransky D, Ray JG, Gowda H, Chatterjee A (2021) Proteomic alterations associated with oral cancer patients with tobacco using habits. OMICS 25:255–268. https://doi.org/10.1089/omi.2021.0001
Calderwood SK (2013) Molecular cochaperones: tumor growth and cancer treatment. Scientifica 2013:1–13. https://doi.org/10.1155/2013/217513
Deutsch EW, Csordas A, Sun Z, Jarnuczak A, Perez-Riverol Y, Ternent T, Campbell DS, Bernal-Llinares M, Okuda S, Kawano S, Moritz RL, Carver JJ, Wang M, Ishihama Y, Bandeira N, Hermjakob H, Vizcaíno JA (2017) The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition. Nucleic Acids Res 45(D1):D1100–D1106. https://doi.org/10.1093/nar/gkw936
Dey S, Basu S, Ranjan A (2023) Revisiting the Role of CD63 as pro-tumorigenic or anti-tumorigenic tetraspanin in cancers and its theragnostic implications. Adv Biol. https://doi.org/10.1002/adbi.202300078
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed 28 March 2024.
Gao G, Kun T, Sheng Y, Qian M, Kong F, Liu X, Yu Z, Zhang H, Zhang Q, Gu J, Zhang X (2013) SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells. Mol Biol Rep 40:2947–2953. https://doi.org/10.1007/s11033-012-2363-8
Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3:733–744. https://doi.org/10.1038/nrc1190
Javid J, Mir R, Julka PK, Ray PC, Saxena A (2015) Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients. Tumor Biol 36:4253–4260. https://doi.org/10.1007/s13277-015-3062-6
Jeong M, Jang E, Choi SS, Ji C, Lee K, Youn J (2017) The function of FK506-binding protein 13 in protein quality control protects plasma cells from endoplasmic reticulum stress-associated apoptosis. Front Immunol. https://doi.org/10.3389/fimmu.2017.00222
Kwon MS, Shin S-H, Yim S-H, Lee KY, Kang H-M, Kim T-M, Chung Y-J (2007) CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung. Lung Cancer 57:46–53. https://doi.org/10.1016/j.lungcan.2007.01.032
Lai X, Gu Q, Zhou X, Feng W, Lin X, He Y, Cao J, Liu P, Zhang H, Zheng X (2017) Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer. Oncol Lett 13:4245–4251. https://doi.org/10.3892/ol.2017.6023
Lee Y-T, Jacob J, Michowski W, Nowotny M, Kuznicki J, Chazin WJ (2004) Human Sgt1 binds HSP90 through the CHORD-Sgt1 domain and not the tetratricopeptide repeat domain. J Biol Chem 279:16511–16517. https://doi.org/10.1074/jbc.M400215200
Li R-N, Wu C-J, Yu Z-J, Chang H-W, Liang S-S (2014) Networks development between nicotinic chemical probes and Ca9-22 oral cancer cells by general proteomics analyses. Electrophoresis 35:2213–2221. https://doi.org/10.1002/elps.201400150
Li P, Bian X, Chen Q, Yao X, Wang X, Zhang W, Tao Y, Jin R, Zhang L (2017) Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma. PLoS ONE 12:e0177484. https://doi.org/10.1371/journal.pone.0177484
Lim K-H, Kim K-H, Il CS, Park E-S, Park SH, Ryu K, Park YK, Kwon SY, Yang S-I, Lee HC, Sung I-K, Seong BL (2011) RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function. PLoS ONE 6:e22258. https://doi.org/10.1371/journal.pone.0022258
Lin B, Li Y, Wang T, Qiu Y, Chen Z, Zhao K, Lu N (2020) CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK. Oncogene 39:6024–6040. https://doi.org/10.1038/s41388-020-01412-x
Liu W, Li X, Zhu X, Hou M, Zhao W (2018) CD63 inhibits the cell migration and invasion ability of tongue squamous cell carcinoma. Oncol Lett. https://doi.org/10.3892/ol.2018.8499
Liu Z, Zhao X, Zhang L, Pei B (2019) Cytochrome C inhibits tumor growth and predicts favorable prognosis in clear cell renal cell carcinoma. Oncol Lett 18:6026–6032. https://doi.org/10.3892/ol.2019.10989
Malik UU, Siddiqui IA, Ilyas A, Hashim Z, Staunton L, Kwasnik A, Pennington SR, Zarina S (2020) Identification of differentially expressed proteins from smokeless tobacco addicted patients suffering from oral squamous cell carcinoma. Pathol Oncol Res 26:1489–1497. https://doi.org/10.1007/s12253-019-00724-y
Marchenko ND, Moll UM (2014) Mitochondrial death functions of p53. Mol Cell Oncol 1:e955995. https://doi.org/10.1080/23723548.2014.955995
Marintchev A, Wagner G (2004) Translation initiation: structures, mechanisms and evolution. Q Rev Biophys 37:197–284. https://doi.org/10.1017/S0033583505004026
Metsalu T, Vilo J (2015) ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res 43:W566–W570. https://doi.org/10.1093/nar/gkv468
Mohanty V, Subbannayya Y, Patil S, Abdulla R, Ganesh MS, Pal A, Ray JG, Sidransky D, Gowda H, Prasad TSK, Chatterjee A (2021) Molecular alterations in oral cancer between tobacco chewers and smokers using serum proteomics. Cancer Biomark 31:361–373. https://doi.org/10.3233/CBM-203077
Morales X, Peláez R, Garasa S, de Solórzano CO, Rouzaut A (2021) Crmp2 as a candidate target to interfere with lung cancer cell migration. Biomolecules. https://doi.org/10.3390/biom11101533
Nair S, Datta S, Thiagarajan S, Chakrabarti S, Nair D, Chaturvedi P (2016) Squamous cell carcinoma of the upper aerodigestive tract in exclusive smokers, chewers, and those with no habits. Indian J Cancer 53:538–541. https://doi.org/10.4103/0019-509X.204759
Naora H, Naora H (1999) Involvement of ribosomal proteins in regulating cell growth and apoptosis: translational modulation or recruitment for extraribosomal activity? Immunol Cell Biol 77:197–205. https://doi.org/10.1046/j.1440-1711.1999.00816.x
Ogi H, Sakuraba Y, Kitagawa R, Xiao L, Shen C, Cynthia MA, Ohta S, Arnold MA, Ramirez N, Houghton PJ, Kitagawa K (2015) The oncogenic role of the cochaperone Sgt1. Oncogenesis 4:e149–e149. https://doi.org/10.1038/oncsis.2015.12
Pascual-Caro C, Orantos-Aguilera Y, Sanchez-Lopez I, de Juan-Sanz J, Parys JB, Area-Gomez E, Pozo-Guisado E, Martin-Romero FJ (2020) STIM1 deficiency leads to specific down-regulation of ITPR3 in SH-SY5Y cells. Int J Mol Sci. https://doi.org/10.3390/ijms21186598
Pathania S, Khan MI, Bandyopadhyay S, Singh SS, Rani K, Parashar TR, Jayaram J, Mishra PR, Srivastava A, Mathur S, Hari S, Vanamail P, Hariprasad G (2022) iTRAQ proteomics of sentinel lymph nodes for identification of extracellular matrix proteins to flag metastasis in early breast cancer. Sci Rep 12:8625. https://doi.org/10.1038/s41598-022-12352-9
Patil S, Babu N, Subbannayya T, Mohan SV, Sathe G, Solanki HS, Rajagopalan P, Patel K, Advani J, Bhandi S, Sidransky D, Chatterjee A, Gowda H, Ferrari M (2019) Secretome analysis of oral keratinocytes chronically exposed to shisha. Cancer Biomark 25:29–41. https://doi.org/10.3233/CBM-182099
Pérez-Sayáns (2009) Genetic and molecular alterations associated with oral squamous cell cancer (review). Oncol Rep. https://doi.org/10.3892/or_00000565
Rana R, Huirem RS, Kant R, Chauhan K, Sharma S, Yashavarddhan MH, Chhabra SS, Acharya R, Kalra SK, Gupta A, Jain S, Ganguly NK (2022) Cytochrome C as a potential clinical marker for diagnosis and treatment of glioma. Front Oncol. https://doi.org/10.3389/fonc.2022.960787
Ren R, Li Y (2023) STIM1 in tumor cell death: angel or devil? Cell Death Discov 9:408. https://doi.org/10.1038/s41420-023-01703-8
Sarkar R, Kishida S, Kishida M, Nakamura N, Kibe T, Karmakar D, Chaudhuri CR, Barui A (2019) Effect of cigarette smoke extract on mitochondrial heme-metabolism: an in vitro model of oral cancer progression. Toxicol in Vitro 60:336–346. https://doi.org/10.1016/j.tiv.2019.06.016
Scheidt JHG, Yurgel LS, Cherubini K, de Figueiredo MAZ, Salum FG (2012) Characteristics of oral squamous cell carcinoma in users or non users of tobacco and alcohol. Revista Odonto Ciência 27:69–73. https://doi.org/10.1590/S1980-65232012000100013
Sehrawat U, Pokhriyal R, Gupta AK, Hariprasad R, Khan MI, Gupta D, Naru J, Singh SB, Mohanty AK, Vanamail P, Kumar L, Kumar S, Hariprasad G (2016) Comparative proteomic analysis of advanced ovarian cancer tissue to identify potential biomarkers of responders and nonresponders to first-line chemotherapy of carboplatin and paclitaxel. Biomark Cancer. https://doi.org/10.4137/BIC.S35775
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504. https://doi.org/10.1101/gr.1239303
Sharma V, Bandyopadhyay S, Sikka K, Kakkar A, Hariprasad G, Singh SB (2023) Label-free proteomics of oral mucosa tissue to identify potential biomarkers that can flag predilection of precancerous lesions to oral cell carcinoma: a preliminary study. Dis Mark 2023:1–16. https://doi.org/10.1155/2023/1329061
Shimada K, Ishikawa T, Nakamura F, Shimizu D, Chishima T, Ichikawa Y, Sasaki T, Endo I, Nagashima Y, Goshima Y (2014) Collapsin response mediator protein 2 is involved in regulating breast cancer progression. Breast Cancer 21:715–723. https://doi.org/10.1007/s12282-013-0447-5
Slizhikova DK, Vinogradova TV, Sverdlov ED (2005) The NOLA2 and RPS3A genes as highly informative markers of human squamous cell carcinoma of lung. Russ J Bioorg Chem 31:178–182. https://doi.org/10.1007/s11171-005-0024-6
Soe ZY, Park EJ, Shimaoka M (2021) Integrin regulation in immunological and cancerous cells and exosomes. Int J Mol Sci. https://doi.org/10.3390/ijms22042193
Speight PM, Farthing PM, Bouquot JE (1996) The pathology of oral cancer and precancer. Curr Diagn Pathol 3:165–176. https://doi.org/10.1016/S0968-6053(05)80014-6
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, Nice EC, Tang J, Huang C (2023) Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci 15:44. https://doi.org/10.1038/s41368-023-00249-w
Toricelli M, Melo FHM, Peres GB, Silva DCP, Jasiulionis MG (2013) Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Mol Cancer 12:22. https://doi.org/10.1186/1476-4598-12-22
Vaysse C, Philippe C, Martineau Y, Quelen C, Hieblot C, Renaud C, Nicaise Y, Desquesnes A, Pannese M, Filleron T, Escourrou G, Lawson M, Rintoul RC, Delisle MB, Pyronnet S, Brousset P, Prats H, Touriol C (2015) Key contribution of eIF4H-mediated translational control in tumor promotion. Oncotarget 6(37):39924–39940
Vizcaíno JA, Csordas A, del-Toro N, Dianes JA, Griss J, Lavidas I, Mayer G, Perez-Riverol Y, Reisinger F, Ternent T, Xu QW, Wang R, Hermjakob H (2016) 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. https://doi.org/10.1093/nar/gkv1145
Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761–772. https://doi.org/10.1038/nrc1716
Xu J, Gimenez-Conti IB, Cunningham JE, Collet AM, Luna MA, Lanfranchi HE, Spitz MR, Conti CJ (1998) Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 83:204–212. https://doi.org/10.1002/(sici)1097-0142(19980715)83:2%3c204::aid-cncr2%3e3.0.co;2-q
Zhou C, Weng J, Liu C, Zhou Q, Chen W, Hsu JL, Sun J, Atyah M, Xu Y, Shi Y, Shen Y, Dong Q, Hung M-C, Ren N (2020) High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients. Am J Cancer Res 10:2768–2784
Zhou Z, Arroum T, Luo X, Kang R, Lee YJ, Tang D, Hüttemann M, Song X (2024) Diverse functions of cytochrome c in cell death and disease. Cell Death Differ. https://doi.org/10.1038/s41418-024-01284-8
Acknowledgements
Funding from DST (EEQ/2018/001412) is acknowledged.
Funding
Department of Science and Technology, Ministry of Science and Technology, India, EEQ/2018/001412,EEQ/2018/001412.
Author information
Authors and Affiliations
Contributions
GH and SBS conceptualized the work and procured funding. KS screened and recruited patients. AK did the histopathology analysis for clinical phenotyping. VS, MVR, SB, GH performed the experiments. VS and GH did the analysis and drafted the manuscript. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sharma, V., Rajan, M.V., Singh, S.B. et al. Comparative proteomics of oral squamous cell carcinoma tissue in consumers and non-consumers of tobacco. J Proteins Proteom 15, 577–586 (2024). https://doi.org/10.1007/s42485-024-00151-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42485-024-00151-x